AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 167 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $531,000 | -82.5% | 70,003 | -85.4% | 0.00% | -50.0% |
Q4 2019 | $3,032,000 | +156.5% | 479,636 | +59.0% | 0.00% | 0.0% |
Q3 2019 | $1,182,000 | -0.8% | 301,603 | +22.5% | 0.00% | 0.0% |
Q2 2019 | $1,192,000 | -48.6% | 246,266 | -13.0% | 0.00% | -33.3% |
Q1 2019 | $2,318,000 | +50.0% | 283,044 | +1.3% | 0.00% | +50.0% |
Q4 2018 | $1,545,000 | – | 279,378 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |